Common questions about Sabrilex (FAQ)
Q: How quickly does Sabrilex start to work?
Official information does not precisely document the onset of the clinical effect. However, studies show that the drug reaches its maximum concentration in the bloodstream approximately 1 hour after an oral dose in adults, and around 2.5 hours in infants. This measure indicates the drug's absorption rate.
Q: Is Sabrilex considered a first-line treatment for seizures?
According to the official product information, Sabrilex is not indicated as a first-line agent for the treatment of complex partial seizures. It is approved for use after other treatments have been tried.
Q: How long does it take to see the full therapeutic effect of Sabrilex?
The time required to see a clear benefit depends on the condition being treated. For complex partial seizures, clinical benefit is assessed after 3 months of treatment. For infantile spasms, the benefit is assessed sooner, typically within 2 to 4 weeks.
Q: Can I take Sabrilex for an extended period, or is it for short-term use?
Official guidance indicates that the need for continued treatment is periodically reassessed. The risk of vision loss, a major concern with this drug, increases with the total dose and the duration of use. For complex partial seizures, treatment may be withdrawn if no substantial benefit is seen after 3 months.
Q: Does the medicine build up in my system over time?
Regulatory documents indicate that there was little accumulation of the drug in the system when multiple doses were given in clinical studies. This suggests the drug is consistently cleared from the body between doses.
Q: How long does Sabrilex stay in my system after I stop taking it?
The drug is eliminated mainly through the kidneys. The time it takes for half the drug to be eliminated, known as the terminal half-life, is approximately 10.5 hours in adults.
Q: Will Sabrilex affect my weight?
Official reports indicate that weight gain is listed as a common adverse reaction that was observed during clinical trials for the medication.
Q: What are the long-term safety risks of Sabrilex?
Long-term use is associated with several safety risks, the most serious being permanent bilateral concentric visual field constriction, which results in vision loss. Other risks noted in official documents include peripheral neuropathy and, in infants, magnetic resonance imaging (MRI) abnormalities.
Q: Can Sabrilex cause vision problems or changes?
Yes, official information includes a Boxed Warning about vision problems. The drug can cause a serious and permanent condition called bilateral concentric visual field constriction, often referred to as 'tunnel vision'.
Q: Does Sabrilex make you sleepy or tired?
Somnolence, which is a state of sleepiness or strong drowsiness, and fatigue (tiredness) are listed in official documents as common adverse reactions associated with treatment.
Q: Will Sabrilex affect my mood or behavior?
The drug is associated with an increased risk of suicidal thoughts and behavior. Other potential adverse reactions are described in official documents, including aggression, agitation, and confusional states.
Q: Does Sabrilex affect the liver or kidneys?
The drug is eliminated primarily through the kidneys. Because of this, dose adjustments may be necessary for patients with kidney impairment, as specified in regulatory information. The drug can also affect laboratory tests by reducing plasma ALT and AST activity, which may obscure a true assessment of liver function.
Q: Can I drink alcohol while taking Sabrilex?
Official warnings describe that alcohol may increase the nervous system side effects of the medication. Combining alcohol with Sabrilex may result in increased dizziness, drowsiness, and difficulty concentrating.
Q: Can I take over-the-counter (OTC) pain relievers like Tylenol (acetaminophen) or ibuprofen with Sabrilex?
The official patient counseling information advises informing a healthcare provider of all concomitant medications. This includes over-the-counter drugs, and regulatory guidance emphasizes informing a provider of all medications, as interactions are possible.
Q: Are there any foods I need to avoid while on Sabrilex?
Official regulatory information states that this medication may be taken with or without food. No specific food restrictions are listed on the label.
Q: Can I take vitamins or herbal supplements with Sabrilex?
Official guidance advises that a healthcare provider should be informed of all other products being used. This includes herbal supplements and vitamins, as interactions are possible.
Q: Can I take cold or flu medication with Sabrilex?
As with any medication, the patient counseling information advises notifying a healthcare provider of all concomitant medications. This is important for cold or flu remedies, as they may contain ingredients that could interact with Sabrilex.
Q: Should I avoid any specific prescription drugs while taking Sabrilex?
Official documents advise avoiding use with other drugs known to cause serious adverse ophthalmic effects, such as retinopathy or glaucoma. A decrease in the plasma levels of another anti-seizure drug, phenytoin, has also been reported.
Q: Can I stop taking my other anti-seizure medication when I start Sabrilex?
If a patient needs to stop using other anti-seizure medications, the dose is generally required to be tapered gradually, according to official protocol. This is done to minimize the possibility of withdrawal seizures.
Q: Is Sabrilex safe to take during pregnancy or while breastfeeding?
For pregnancy, animal data suggests the drug carries a potential risk of fetal harm, and a Pregnancy Registry is available for monitoring. For breastfeeding, official information states the drug is excreted in human milk and may harm the baby.
Q: Is Sabrilex safe for children under 2 years old?
Official documents describe that the drug is used as monotherapy for pediatric patients with infantile spasms (IS) who are aged 1 month to 2 years.
Q: What are the contraindications for taking Sabrilex?
A contraindication is a specific condition or factor that prevents the use of a drug. The regulatory label for this product lists no specific contraindications.
Q: Can I take Sabrilex if I have a history of depression or other psychiatric conditions?
Patients with a history of depression, a mood disorder, or mental illness should use the drug with caution. The drug is associated with an increased risk of suicidal thoughts and behavior and may make pre-existing mental health conditions worse.
Q: Can Sabrilex make my seizures worse?
Official information describes that the drug carries a risk of worsening certain types of seizures.
Q: Is Sabrilex a controlled substance?
No, vigabatrin is not a controlled substance in the U.S. and has a Drug Enforcement Administration (DEA) Schedule of None.
Q: Can children 2 years old use Sabrilex?
Yes, official documents indicate that the drug is approved as adjunctive therapy for refractory complex partial seizures in pediatric patients who are 2 years of age and older.
Q: Can Sabrilex be used to treat other types of epilepsy or seizures not listed in the label?
The official prescribing information indicates that the drug is only approved for the treatment of refractory complex partial seizures and infantile spasms.
Q: Does Sabrilex cause any side effects that are permanent?
Yes, the most serious long-term side effect is permanent bilateral concentric visual field constriction, which causes irreversible vision loss. This risk is highlighted in the drug's official warnings.
Q: What are the most common side effects of Sabrilex?
The most common adverse reactions reported in adults include somnolence (sleepiness), fatigue, tremor, weight gain, blurred vision, and memory impairment.
Q: How should I store Sabrilex (tablets and powder)?
The powdered form of the drug is intended to be dissolved in cold or room-temperature water. The official instructions state that the prepared solution must be administered immediately after preparation.
Q: Can Sabrilex cause issues with vision loss?
Yes, Sabrilex carries a Boxed Warning because it can cause progressive and permanent bilateral concentric visual field constriction (vision loss). This condition is generally irreversible.
